Risk Factors Affecting Muscle Mass Decline in Maintenance Hemodialysis Patients

Objective There is a high prevalence of sarcopenia in maintenance hemodialysis (MHD) patients, which is known to be associated with increased mortality. This study is aimed at analyzing the risk factors affecting muscle mass decline in MHD patients. Methods This retrospective study included MHD patients who underwent two body composition assessments in October 2013 and November 2017. Depending on whether there was muscle loss or not, the patients were divided into a normal muscle mass (NMM) group and a muscle mass decline (MMD) group. According to the muscle mass decline rate, patients in the MMD group were further classified into a low-rate group and a high-rate group. Biochemical variables, serum vitamin concentrations, anthropometric data, SGA, muscle mass, handgrip, and daily steps were assessed. Risk factors for muscle mass decline were screened by multivariate logistic analysis and linear regression analysis. Results Of the 72 MHD patients included in this study, 33 were male and 39 were female with a mean age of 56.80 ± 10.86 years and a mean dialysis duration of 7.50 ± 5.20 years. Age (P = .014) and serum 25(OH)D (P = .040) were found to be associated with a higher risk of muscle mass decline after adjusting for gender, dialysis vintage, albumin, and hs-CRP (P = .040). Further analysis found that dialysis vintage (β = 0.285, P = .030), 25(OH)D (β = −0.351, P = .007), and log NT-proBNP (β = 0.312, P = .020) were risk factors associated with the muscle mass decline rate in MHD patients. Conclusion Age and serum 25(OH)D were associated with a higher risk of muscle mass decline, while 25(OH)D, dialysis vintage, and NT-proBNP were associated with the muscle mass decline rate in MHD patients.

[1]  H. Liou,et al.  Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[2]  P. Newsholme,et al.  Mechanisms of vitamin D action in skeletal muscle , 2019, Nutrition research reviews.

[3]  Hiroshi Takahashi,et al.  The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis , 2019, PloS one.

[4]  N. Bansal,et al.  Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  P. Darmon,et al.  The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. , 2017, Clinical nutrition.

[6]  P. Soysal,et al.  Vitamin B12 deficiency might be related to sarcopenia in older adults , 2017, Experimental Gerontology.

[7]  Matteo Cesari,et al.  Measurement of muscle mass in sarcopenia: from imaging to biochemical markers , 2017, Aging Clinical and Experimental Research.

[8]  H. Yasuda,et al.  Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients , 2017, European Journal of Clinical Nutrition.

[9]  Keiko Takahashi,et al.  N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients , 2016, PloS one.

[10]  M. Amini,et al.  Vitamin B12 supplementation in end stage renal diseases: a systematic review , 2015, Medical journal of the Islamic Republic of Iran.

[11]  J. Carrero,et al.  Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[12]  S. Walrand,et al.  Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old wistar rats , 2014, Nutrition & Metabolism.

[13]  W. Mitch,et al.  Mechanisms of muscle wasting in chronic kidney disease , 2014, Nature Reviews Nephrology.

[14]  J. Reginster,et al.  The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. , 2014, The Journal of clinical endocrinology and metabolism.

[15]  A. Covic,et al.  Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients , 2014, International Urology and Nephrology.

[16]  C. Wanner,et al.  Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. , 2013, Kidney international.

[17]  M. Holick,et al.  The roles of vitamin D in skeletal muscle: form, function, and metabolism. , 2013, Endocrine reviews.

[18]  P. Stenvinkel,et al.  N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients , 2008, American Journal of Nephrology.

[19]  K. Johansen,et al.  Relationship between vitamin D and muscle size and strength in patients on hemodialysis. , 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[20]  D. Knol,et al.  Vitamin D status predicts physical performance and its decline in older persons. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  G. Handelman.  Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  C. Hamm,et al.  Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine , 2005, Heart.

[23]  S. Greenland,et al.  Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  D. Oliver,et al.  Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease , 2004, American Journal of Nephrology.

[25]  F. Dekker,et al.  Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. , 2004, Journal of the American Society of Nephrology : JASN.

[26]  Craig S. Wong,et al.  Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. , 2002, Kidney international.